(Q36299926)

13 August 2017

1 reference

title

IL-7 as a potential therapy for HIV-1-infected individuals (English)

1 reference

13 August 2017

1

Giuseppe Nunnari

1 reference

13 August 2017

2

Roger J Pomerantz

1 reference

13 August 2017

language of work or name

English

0 references

publication date

1 November 2005

1 reference

Expert Opinion on Biological Therapy

13 August 2017

published in

1 reference

13 August 2017

volume

5

1 reference

13 August 2017

issue

11

1 reference

13 August 2017

page(s)

1421-1426

1 reference

Residual HIV-1 replication

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.11.1421

Residual HIV-1 RNA in blood plasma of patients taking suppressive highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.11.1421

Reservoirs of human immunodeficiency virus type 1: the main obstacles to viral eradication

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.11.1421

Approaching eradication of highly active antiretroviral therapy-persistent human immunodeficiency virus type 1 reservoirs with immune activation therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.11.1421

Enfuvirtide: antiretroviral class 4, drug 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.11.1421

Human immunodeficiency virus type 1 in the semen of men receiving highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.11.1421

Human immunodeficiency virus type 1-infected persons with residual disease and virus reservoirs on suppressive highly active antiretroviral therapy can be stratified into relevant virologic and immunologic subgroups

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.11.1421

Intensification and stimulation therapy for human immunodeficiency virus type 1 reservoirs in infected persons receiving virally suppressive highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.11.1421

Prostratin: activation of latent HIV-1 expression suggests a potential inductive adjuvant therapy for HAART.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.11.1421

Expression of latent HAART-persistent HIV type 1 induced by novel cellular activating agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.11.1421

Residual HIV-1 disease in seminal cells of HIV-1-infected men on suppressive HAART: latency without on-going cellular infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.11.1421

Peripheral blood Dendritic cells are not a major reservoir for HIV type 1 in infected individuals on virally suppressive HAART.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.11.1421

Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.11.1421

Efficacy of low-dose intermittent subcutaneous interleukin (IL)--2 in antiviral drug--experienced human immunodeficiency virus--infected persons with detectable virus load: a controlled study of 3 il-2 regimens with antiviral drug therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.11.1421

Effects of interleukin-2 plus highly active antiretroviral therapy on HIV-1 replication and proviral DNA (COSMIC trial).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.11.1421

Interleukin 7 is produced by human intestinal epithelial cells and regulates the proliferation of intestinal mucosal lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.11.1421

Human follicular dendritic cells and vascular cells produce interleukin-7: a potential role for interleukin-7 in the germinal center reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.11.1421

Cytokine-induced survival of activated T cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.11.1421

Interleukin 4 (IL-4) or IL-7 prevents the death of resting T cells: stat6 is probably not required for the effect of IL-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.11.1421

Growth factors can enhance lymphocyte survival without committing the cell to undergo cell division

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.11.1421

Interleukin 2-independent interleukin 7 activity enhances cytotoxic immune response of HIV-1-infected individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.11.1421

Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.11.1421

Cloning of the human and murine interleukin-7 receptors: demonstration of a soluble form and homology to a new receptor superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.11.1421

Cytokines and immunodeficiency diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.11.1421

Shared gamma(c) subunit within the human interleukin-7 receptor complex. A molecular basis for the pathogenesis of X-linked severe combined immunodeficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.11.1421

The role of shared receptor motifs and common Stat proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, IL-13, and IL-15.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.11.1421

Interleukin-7 receptor expression and activation in nonhaematopoietic neoplastic cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.11.1421

Cytokine signal transduction and the JAK family of protein tyrosine kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.11.1421

Serine/threonine protein kinases and apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.11.1421

Homeostasis of naive and memory CD4+ T cells: IL-2 and IL-7 differentially regulate the balance between proliferation and Fas-mediated apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.11.1421

Increased production of IL-7 accompanies HIV-1-mediated T-cell depletion: implications for T-cell homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.11.1421

Interleukin-7 in plasma correlates with CD4 T-cell depletion and may be associated with emergence of syncytium-inducing variants in human immunodeficiency virus type 1-positive individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.11.1421

Interleukin-7 induces expression of latent human immunodeficiency virus type 1 with minimal effects on T-cell phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.11.1421

Cytokine signals are sufficient for HIV-1 infection of resting human T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.11.1421

Reduction of the HIV-1-infected T-cell reservoir by immune activation treatment is dose-dependent and restricted by the potency of antiretroviral drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.11.1421

Induction of HIV-1 replication in latently infected CD4+ T cells using a combination of cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.11.1421

OKT3 and IL-2 treatment for purging of the latent HIV-1 reservoir in vivo results in selective long-lasting CD4+ T cell depletion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.11.1421

IL-7 Stimulates T Cell Renewal Without Increasing Viral Replication in Simian Immunodeficiency Virus-Infected Macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.11.1421

Molecular Characterization, Reactivation, and Depletion of Latent HIV

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.11.1421

Cross-talk and viral reservoirs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.5.11.1421

10.1517/14712598.5.11.1421

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference